跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Hesminsaph-500 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Hesminsaph-500
Approved
STANDARD
Hesminsaph-500
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b88691b17f76ba68
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
b88691b17f76ba68
Drug Approval Philippines Name
Hesminsaph-500
Product Name
Hesminsaph-500
Registration Number
DRP-12712
Brand Name
Hesminsaph-500
Generic Name
Diosmin + Hesperidin
Dosage Form
Film-Coated Tablet
Dosage Strength
450 mg/50 mg
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
Ollen Pharma Trading Inc.
Distributor
Ollen Pharma Trading Inc.
Issuance Date
28 September 2022
Expiry Date
28 September 2027
Pharmacologic Category
Vasoprotective
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b88691b17f76ba68
Type
Standard
Back to Philippines FDA Approvals